TG Therapeutics | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Alaunos Therapeutics USD 0 0 2024-12
Amgen USD 56.55B 305M 2024-12
Ardelyx USD 150.85M 50.15M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Dynavax Technologies USD 223.85M 293K 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
J&J USD 30.65B 638M 2024-12
Novartis USD 22.93B 2.41B 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
TG Therapeutics USD 244.43M 271K 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



TG Therapeutics Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.